Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 4 p.m. in New York.
Gold producers fell as the metal dropped the most since March 2008.
AuRico Gold Inc. (AUQ US) lost 6 percent to $12.96. Yamana Gold Inc. (AUY) slipped 1.8 percent to $15.03. Barrick Gold Corp. (ABX) decreased 3.4 percent to $48.99. Goldcorp Inc. (G) lost 3.6 percent to $49.44. Eldorado Gold Corp. (EGO) declined 2.9 percent to $18.61. Newmont Mining Corp. (NEM) sank 1.6 percent to $60.26.
Hotel and casino stocks gained after Sanford C. Bernstein & Co. said the group may beat earnings estimates as demand from high-end consumers is holding up. Starwood Hotels & Resorts Worldwide Inc. (HOT) climbed 5.3 percent to $42.93. MGM Resorts International (MGM) jumped 11 percent to $10.24.
Homebuilders advanced after a report from the Federal Housing Finance Agency showed home prices increased more than expected in June from the previous month. D.R. Horton Inc. (DHI US) rose 5.7 percent to $9.45. Toll Brothers Inc. (TOL) climbed 4.6 percent to $15.42.
American Eagle Outfitters Inc. (AEO) declined 8.8 percent, the most since May 2009, to $10.60. The teen retailer lowered its forecast for earnings in 2012 to as little as 85 cents a share, down from an earlier projection of $1.02 and below the average analyst estimate of 93 cents.
Avago Technologies Ltd. (AVGO) rallied 10 percent, the most since its initial public offering in August 2009, to $32.27. The maker of semiconductor components forecast fourth- quarter revenue to be as much as $633.2 million, exceeding the average analyst estimate of $621 million.
Bank of America Corp. (BAC) rose the most in the Standard & Poor’s 500 Index, climbing 11 percent to $6.99. The biggest U.S. lender has no urgent need to raise capital, said Meredith Whitney, the bank analyst who correctly predicted Citigroup Inc.’s dividend cut three years ago. The stock may triple, according to Raymond James Financial Inc.
Calpine Corp. (CPN) increased 5.8 percent, the most since July 2009, to $13.95. The U.S. power developer and supplier said it plans to buy back up to $300 million shares of its common stock.
Dycom Industries Inc. (DY) jumped 15 percent, the most since May 2009, to $15.97. The provider of contract services to phone and cable companies reported fourth-quarter earnings and sales that beat analysts’ estimates.
Inphi Corp. (IPHI) slumped 31 percent to $7.20, the lowest price since it went public in November. The semiconductor company reduced its third-quarter forecast and withdrew its projection for the last three months of the year, citing lower- than-expected demand.
McGraw-Hill Cos. (MHP US) climbed 7.4 percent to $41.30 for the second-biggest gain in the S&P 500. The owner of Standard & Poor’s may be worth at least 40 percent more if sold and broken into pieces, analysts and investors told Bloomberg News.
Micron Technology Inc. (MU) lost 6.4 percent to $5.30 for the first decline in three days. The largest U.S. maker of computer-memory chips saw a drop in demand for memory used in personal computers starting last month, Mark Adams, head of sales at Micron, said today at a company event.
Advanced Micro Devices Inc. (AMD) , another chipmaker, slipped 2.5 percent to $6.34.
Pacific Sunwear of California Inc. (PSUN) plunged 32 percent, the most in the Russell 2000 Index, to $1.47. The athletic apparel retailer forecast a third-quarter loss that’s wider than analysts estimated.
Peregrine Pharmaceuticals Inc. (PPHM) rose 8.4 percent, the most since July 13, to $1.42. The developer of antibodies to treat cancer and viral infections said its breast cancer treatment showed “promising” results in a phase 2 trial.
Swift Transportation Co. (SWFT US) gained 15 percent, the most since its IPO in December, to $7.96. The biggest truckload carrier in North America’s chief executive officer, Jerry Moyes, bought shares earlier this week, a regulatory filing showed.
United Therapeutics Corp. (UTHR) lost 18 percent to $39.91 for the biggest retreat in the Russell 1000 Index. The pharmaceutical company said the oral version of the drug known as treprostinil for patients with pulmonary arterial hypertension didn’t meet the primary endpoint in a trial. The Silver Spring, Maryland-based company was cut to “hold” from “buy” at Deutsche Bank AG.
To contact the reporter on this story: Nikolaj Gammeltoft in New York at email@example.com
To contact the editor responsible for this story: Nick Baker at firstname.lastname@example.org